Navigation Links
Industry-First Telephone for Health Care Developed by CyraCom
Date:9/26/2007

Hospital Trials Complete for Limited-English Interpretation

TUCSON, Ariz., Sept. 26 /PRNewswire/ -- Clinically relevant timing, especially important for serving limited-English speaking patients in hospitals and health care facilities, is now markedly enhanced with the development of the industry's first dual-handset cordless phone, ClearLink(TM) Cordless.

Precedent-setting, as was CyraCom's invention of its patented dual-handset phone now known as ClearLink(TM), this new cordless phone is specifically designed for medical interpretation in health care settings. ClearLink(TM) Cordless also is patented, with an additional patent pending.

The ClearLink(TM) Cordless mobile dual-handsets provide access for language interpretation service in nearly any patient care environment. It is particularly well-suited for use in emergency, labor and delivery, physical therapy and occupational medicine departments, as well as out-patient clinics. It provides improved access to over-the-phone interpretation in areas of health care facilities with limited phone access. Another advantage of its mobility is that it enhances workflow by allowing caregivers to sequentially treat patients with a common language need while connected to the same interpreter.

ClearLink(TM) Cordless has belt clips and headsets to give caregivers more freedom of movement. Its high quality speakerphone features, including a handset volume control, enable hands-free communication. The smooth surface has a specially designed coating unique to ClearLink(TM) that helps ensure effective infection control.

"This new cordless phone can easily be set up for interpretation service when clinicians need it, and virtually anywhere," said CyraCom CEO Michael Greenbaum. CyraCom introduced its first patented dual-handset phone in 1995.

Leading hospitals nationwide have trialed ClearLink(TM) Cordless as part of CyraCom's ongoing program of bringing innovative products and services to its clients.

"By providing high quality sound and mobility, the ClearLink(TM) Cordless handsets and headset option make over-the-phone interpretation much more effective while treating patients during physical therapy treatment," said Nancy L. Gessner, Chief Physical Therapist, South Nassau Communities Hospital.

CyraCom's now serves more than 1,000 hospitals and health care facilities nationwide. Its language services include on-demand telephonic interpretation, document translation and medical interpreter testing and training. Its technology won a national health care award from InfoWorld magazine. The company has been named to both the Inc. 500 and Inc. 5000 lists of fastest-growing private companies in the United States.

For more information about ClearLink(TM) Cordless, call 800-713-4950 or visit http://www.cyracom/news


'/>"/>
SOURCE CyraCom
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The ABCs of telephone regulation in Wisconsin
2. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
3. Web-based reporting credited with states top healthcare ranking
4. Visions, Part II: Preizler sees IT leading incremental health system change
5. Visions: Preizler offers insurers perspective on healthcare IT
6. Federal bill would set healthcare IT standards
7. IRS ruling could speed healthcare technology adoption
8. Bill would provide federal aid for healthcare IT
9. Cardinal Health likes growth potential of Viasys NeuroCare Group
10. DHC 2007: Controlling health IT costs the key to capturing value
11. Siemens health services president calls IT benefits unassailable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
(Date:2/23/2017)... Feb. 23, 2017 Aviva Systems Biology ... the acquisition of GenWay Biotech Incorporated, a protein ... and product offering for both the research and ... growth and enhance capabilities for both entities. GenWay,s 18 ... assays will nicely complement ASB,s objective to become ...
Breaking Biology Technology:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
Breaking Biology News(10 mins):